Constance Therapeutics Overview
- Founded
-
2015
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$4.75M
- Investors
-
5
Constance Therapeutics General Information
Description
Producer of medicinal cannabis products intended to offer alternative approaches to treat critically ill patients. The company's products use raw materials with controlled genetics that have been sustainably grown and are also based on modern herbalist principles, enabling physicians to have expanded treatment options.
Contact Information
Website
www.constancetherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Consumer Non-Durables
Pharmaceuticals
Primary Office
- 981 Howard Street
- San Francisco, CA 94103
- United States
+1 (415) 000-0000
Constance Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 05-Mar-2018 | $4.75M | 00.000 | 000.00 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A) | 11-Jul-2016 | 000 | 00.000 | 0000 | Completed | Generating Revenue |
| 1. Angel (individual) | 25-Jun-2015 | $26.6K | $26.6K | Completed | Startup |
Constance Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Constance Therapeutics Patents
Constance Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2016359160-A1 | Cannabis oil compositions and methods for preparation thereof | Inactive | 24-Nov-2015 | 000000000 | |
| CA-3006182-A1 | Cannabis oil compositions and methods for preparation thereof | Pending | 24-Nov-2015 | 000000000 | |
| EP-3380096-A4 | Cannabis oil compositions and methods for preparation thereof | Pending | 24-Nov-2015 | 000000000 | 0 |
| EP-3380096-A1 | Cannabis oil compositions and methods for preparation thereof | Pending | 24-Nov-2015 | 000000000 | |
| US-20210275465-A1 | Cannabis oil compositions and methods for preparation thereof | Pending | 24-Nov-2015 | A61K31/05 |
Constance Therapeutics Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Constance Finley | Founder, Chief Executive Officer and Board Member |
Constance Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Constance Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| ARTIS Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Big Rock | Venture Capital | Minority | 000 0000 | 000000 0 | |
| David Morin | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Ryan O'Halloran | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Slow Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |